ArticleFrontiers in oncology2023

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Kristina Breitenecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.